|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
Overexpression of MMP-1 is
associated with several pathological conditions, including the irreversible
degradation of cartilage, tendon, and bone in arthritis and the degradation
of collagens I and III in tumor invasion and metastasis. Patients with tumors
that express MMP-1 have an overall poorer prognosis than patients with tumors
that do not express this protein. This technology is claimed in
the issued United States Patent Application No. 7,511,025 and the published
United States Patent Application No. 12/352,214. We are seeking an industrial partner interested
in its commercialization. (Ref: J271) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
11 Rope Ferry Road #6210 |
||||
|
Hanover, NH 03755-1404 |
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|